We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

The Promise and Reality of Clinical Trial Transparency Initiatives

What Can Stakeholders Expect from Clinical Trial (Development), Transparency and Medical Information?

Day & Time:
April 19, 10:30AM - 12:00PM (Central Europe Standard Time)

Session Number:

Room Number:


The Promise and Reality of Clinical Trial Transparency Initiatives

Thomas Wicks, MBA
Chief Strategy Officer
Trialscope, United States

The past decade has seen a virtual explosion of trial disclosure requirements and expectations around the world. This panel discussion will discuss the successes, challenges, and opportunities for improvement, looking back over the past ten years and forward to the expected developments in the next five.

Presentation(s) & Speaker(s):
Panel Discussion
Karla Childers, MS
Senior Director, Strategic Projects, Office of the Chief Medical Officer
Johnson & Johnson, United States

Panel Discussion
Deborah E. Collyar
Patient Advocates In Research (PAIR), United States

Panel Discussion
Joao Ferreira, PharmD
Clinical Data Publication Manager
European Medicines Agency (EMA) , United Kingdom

Panel Discussion
Sini Eskola, MPharm, MSc
Director, Regulatory, Drug Development and Manufacturing
European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium

Panel Discussion
Deborah Lincow
Bioethics International, United States